Rft5-Dga
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rft5-Dga, covering 2014-03-04 to 2018-12-14. Get the full timeline:
Most recent: Clinical Trial Update: RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma [Phase 2]